Aim Immunotech share price today

(AIM)

Aim Immunotech share price is $0.2 & ₹17.04 as on 25 Dec 2024, 2.30 'hrs' IST

$0.2

▲

0.01

(3.94%)

Market is closed - opens 8 PM, 26 Dec 2024

View live Aim Immunotech share price in Dollar and Rupees. Guide to invest in Aim Immunotech from India. Also see the sentimental analysis on Indian investors investing in Aim Immunotech. Get details on the Indian mutual funds that are investing in Aim Immunotech. Get Analyst recommendations and forecasts along with all the Aim Immunotech's financials.

Aim Immunotech share price movements

Today's Low: $0.19
Today's High: $0.20
$0.20
6.65%
Downside
Day's Volatility :6.65%
Upside
0.0%
52 Weeks Low: $0.16
52 Weeks High: $0.62
$0.20
18.6%
Downside
52 Weeks Volatility :73.74%
Upside
67.74%

Aim Immunotech Returns

Period	Aim Immunotech Inc	Index (Russel 2000)
3 Months	-27.78%	0.0%
6 Months	-50.0%	0.0%
1 Year	-60.46%	0.0%
3 Years	-80.5%	-21.1%

Aim Immunotech Key Statistics

in dollars & INR

Previous Close	$0.1876
Open	$0.1866
Today's High	$0.2
Today's Low	$0.1867
Market Capitalization	$12.4M
Today's Volume	$143.1K
52 Week High	$0.62
52 Week Low	$0.1628
Revenue TTM	$201.0K
EBITDA	$-31.4M
Earnings Per Share (EPS)	$-0.47
Profit Margin	0.0%
Quarterly Earnings Growth YOY	0.0%
Return On Equity TTM	-154.79%

How to invest in Aim Immunotech from India?

It is very easy for Indian residents to invest directly in Aim Immunotech from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Aim Immunotech stock in both Indian Rupees (INR) and US Dollars (USD). Search for Aim Immunotech or AIM on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Aim Immunotech or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Aim Immunotech shares which would translate to 4.260 fractional shares of Aim Immunotech as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Aim Immunotech, in just a few clicks!

Returns in Aim Immunotech for Indian investors in Rupees

Investment Value

₹1,00,000

Aim Immunotech investment value today

Current value as on today

₹43,055

Returns

₹56,945

(-56.95%)

Returns from Aim Immunotech Stock

₹59,184 (-59.18%)

Dollar Returns

₹2,239 (+2.24%)

Indian investors sentiment towards Aim Immunotech

94%

Period: Sep 26, 2024 to Dec 25, 2024. Change in 30 Days versus previous period

Search volume for Aim Immunotech on INDmoney from India has grown in the last 30 days as on Dec 26, 2024. 94% more investors are searching Aim Immunotech in the last 30 days versus the previous period.

Analyst Recommendation on Aim Immunotech

Buy

85%Buy

14%Hold

0%Sell

Based on 7 Wall street analysts offering stock ratings for Aim Immunotech(by analysts ranked 0 to 5 stars)

Based on 7 analyst

Current
1M Ago
3M Ago

Buy

Hold

Sell

Analyst Forecast on Aim Immunotech

What analysts predicted

Upside of 1275.0%

Current:

$0.20

Target:

$2.75

Insights on Aim Immunotech

Price Movement
In the last 6 months, AIM stock has moved down by -48.1%
Decreasing Revenue
Revenue is down for the last 2 quarters, 50.0K → 35.0K (in $), with an average decrease of 30.0% per quarter
Decreasing Net Profit
Netprofit is down for the last 2 quarters, -1.83M → -3.7M (in $), with an average decrease of 101.5% per quarter
AIM vs ALNY (1 yr)
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 27.2% return, outperforming this stock by 88.6%
AIM vs VRTX (3 yr)
In the last 3 years, Vertex Pharmaceuticals Incorporated has given 25.2% return, outperforming this stock by 107.4%
Price to Sales
ForAIM every $1 of sales, investors are willing to pay $48.8, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $14.7 for every $1 of sales.

Aim Immunotech Technicals Summary

Sell

Neutral

Buy

Aim Immunotech is currently in a neutral trading position according to technical analysis indicators.

Aim Immunotech Vs Peers

Company Name	1 Month	6 Month	1 Year	3 Years	5 Years
Aim Immunotech Inc	-13.33%	-50.0%	-60.46%	-80.5%	-63.29%
Regeneron Pharmaceuticals, Inc.	-5.12%	-32.01%	-18.29%	12.56%	91.19%
Biontech Se	-3.72%	41.99%	6.11%	-55.22%	226.93%
Alnylam Pharmaceuticals, Inc.	-3.99%	-1.52%	23.75%	50.98%	112.09%
Vertex Pharmaceuticals Incorporated	-12.61%	-13.61%	0.03%	83.58%	86.41%

Company Name	P/E Ratio	P/B Ratio	PEG Ratio	EPS	ROE	ROA	Div Yield	BVPS
Aim Immunotech Inc	NA	NA	NA	-0.3	-1.55	-0.8	NA	0.19
Regeneron Pharmaceuticals, Inc.	17.67	17.67	1.06	45.07	0.17	0.07	NA	272.04
Biontech Se	160.8	NA	0.04	-3.11	-0.02	-0.01	NA	79.73
Alnylam Pharmaceuticals, Inc.	NA	NA	-0.49	-0.19	-15.01	-0.03	NA	0.25
Vertex Pharmaceuticals Incorporated	32.84	NA	1.06	0.51	-0.03	0.12	NA	60.65

Company Name	Analyst View	Market Cap	5 Years Return %	PE Ratio	Profit Margin
Aim Immunotech Inc	Buy	$12.4M	-63.29%	NA	0.0%
Regeneron Pharmaceuticals, Inc.	Buy	$78.5B	91.19%	17.67	33.61%
Biontech Se	Buy	$27.4B	226.93%	160.8	-15.36%
Alnylam Pharmaceuticals, Inc.	Buy	$31.4B	112.09%	NA	-15.86%
Vertex Pharmaceuticals Incorporated	Buy	$105.1B	86.41%	32.84	-4.51%

About Aim Immunotech

aim immunotech inc., an immuno-pharma company, focuses on the research and development of therapeutics to treat multiple types of cancers and immune-deficiency disorders in the united states. the company's products include alferon n injection, an injectable formulation of natural alpha interferon to treat a category of genital warts, a sexually transmitted disease; and ampligen, a drug of macromolecular ribonucleic acid molecule for the treatment of chronic fatigue syndrome. it is also developing ampligen for the treatment of hepatitis b and hiv, as well as patients with renal cell carcinoma, malignant melanoma, non-small cell lung, ovarian, breast, colorectal, urothelial, prostate, and pancreatic cancer. aim immunotech inc. has research agreement with the japanese national institute of infectious diseases and shionogi & co., ltd. to test its drug ampligen as an adjuvant therapy for covid-19, the new coronavirus infectious disease caused by sars-cov-2. the company was formerly known as

Organization	Aim Immunotech
Employees	26
CEO	Mr. Thomas K. Equels Esq., J.D., M.S.
Industry	Health Technology

Management People of Aim Immunotech

Name	Title
Mr. Thomas K. Equels Esq., J.D., M.S.	Executive Vice Chairman, CEO & President
Mr. Robert Dickey IV, M.B.A.	Chief Financial Officer
Mr. Peter W. Rodino III, Esq., J.D.	COO, Executive Director of Governmental Relations, General Counsel & Secretary
Dr. Christopher McAleer Ph.D.	Scientific Officer
Ann Marie E. Coverly	Director of Administration & Human Resources and Deputy Investor Relations Coordinator
Dr. Ralph Christopher Cavalli Ph.D.	Vice President of QC & Manufacturing

Important FAQs about investing in Aim Immunotech from India :

What is Aim Immunotech share price today?

Aim Immunotech share price today stands at $0.20, Open: $0.19 ; Previous Close: $0.19 ; High: $0.20 ; Low: $0.19 ; 52 Week High: $0.62 ; 52 Week Low: $0.16. The stock opens at $0.19, after a previous close of $0.19. The stock reached a daily high of $0.20 and a low of $0.19, with a 52-week high of $0.62 and a 52-week low of $0.16.

Can Indians buy Aim Immunotech shares?

Yes, Indians can invest in the Aim Immunotech (AIM) from India.

With INDmoney, you can buy Aim Immunotech at 0 brokerage. The step-by-step process is as follows:

Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
Once funds are transferred successfully, you can buy Aim Immunotech at zero transaction cost.

How can I buy Aim Immunotech shares from India?

It is very easy to buy Aim Immunotech from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Aim Immunotech be purchased?

Yes, you can buy fractional shares of Aim Immunotech with INDmoney app.

What are the documents required to start investing in Aim Immunotech stocks?

To start investing in Aim Immunotech, You will need the following documents:

Proof of Identification (PAN, Aadhaar etc)
Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.